ArticleResearch and practice in thrombosis and haemostasis2021

Safety of idarucizumab in the reversal of dabigatran at six tertiary care Ontario hospitals.

Jameel Abdulrehman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.